AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids

Ruixin Yang1,*Yutong Du1,*Wingyan Kwan1Ranlin Yan1Qimeng Shi1Lu Zang1Zhenggang Zhu1Jianming Zhang2Chen Li1 ( )Yingyan Yu1 ( )
Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
Institute of Translational Medicine, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 201210, China

*These authors contributed equally to this work.

Show Author Information

Abstract

Objective

Organoids are a powerful tool with broad application prospects in biomedicine. Notably, they provide alternatives to animal models for testing potential drugs before clinical trials. However, the number of passages for which organoids maintain cellular vitality ex vivo remains unclear.

Methods

Herein, we constructed 55 gastric organoids from 35 individuals, serially passaged the organoids, and captured microscopic images for phenotypic evaluation. Senescence-associated β-galactosidase (SA-β-Gal), cell diameter in suspension, and gene expression reflecting cell cycle regulation were examined. The YOLOv3 object detection algorithm integrated with a convolutional block attention module (CBAM) was used to evaluate organoid vitality.

Results

SA-β-Gal staining intensity; single-cell diameter; and expression of p15, p16, p21, CCNA2, CCNE2, and LMNB1 reflected the progression of aging in organoids during passaging. The CBAM-YOLOv3 algorithm precisely evaluated aging organoids on the basis of organoid average diameter, organoid number, and number × diameter, and the findings positively correlated with SA-β-Gal staining and single-cell diameter. Organoids derived from normal gastric mucosa had limited passaging ability (passages 1–5), before aging, whereas tumor organoids showed unlimited passaging potential for more than 45 passages (511 days) without showing clear senescence.

Conclusions

Given the lack of indicators for evaluating organoid growth status, we established a reliable approach for integrated analysis of phenotypic parameters that uses an artificial intelligence algorithm to indicate organoid vitality. This method enables precise evaluation of organoid status in biomedical studies and monitoring of living biobanks.

Electronic Supplementary Material

Download File(s)
cbm-20-7-519_ESM.pdf (1.2 MB)

References

1

Wadman M. FDA no longer has to require animal testing for new drugs. Science. 2023; 379: 127–8.

2

Cao J, Chan WC, Chow MSS. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: current and future perspectives (review). Int J Oncol. 2022; 60: 52.

3

Fang G, Lu H, Rodriguez de la Fuente L, Law AMK, Lin G, Jin D, et al. Mammary tumor organoid culture in non-adhesive alginate for luminal mechanics and high-throughput drug screening. Adv Sci (Weinh). 2021; 8: e2102418.

4

Francies HE, Barthorpe A, McLaren-Douglas A, Barendt WJ, Garnett MJ. Drug sensitivity assays of human cancer organoid cultures. Methods Mol Biol. 2019; 1576: 339–51.

5

Xu H, Li W. Early detection of gastric cancer in China: progress and opportunities. Cancer Biol Med. 2022; 19: 1622–8.

6

Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459: 262–65.

7

Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology. 2015; 148: 126–36.

8

Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology. 2011; 141: 1762–72.

9

Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014; 159: 176–87.

10

Boj SF, Hwang CI, Baker LA, Chio Ⅱ, Engle DD, Corbo V, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015; 160: 324–38.

11

Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarró LM, Bradshaw CR, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017; 23: 1424–35.

12

Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018; 172: 373–86.

13

Koh V, Chakrabarti J, Torvund M, Steele N, Hawkins JA, Ito Y, et al. Hedgehog transcriptional effector GLI mediates mTOR-induced PD-L1 expression in gastric cancer organoids. Cancer Lett. 2021; 518: 59–71.

14

Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell. 2018; 23: 882–97.

15

Harada K, Sakamoto N, Ukai S, Yamamoto Y, Pham QT, Taniyama D, et al. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance. Gastric Cancer. 2021; 24: 1264–77.

16

Ukai S, Honma R, Sakamoto N, Yamamoto Y, Pham QT, Harada K, et al. Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell. Oncogene. 2020; 39: 7265–78.

17

Demitrack ES, Gifford GB, Keeley TM, Carulli AJ, VanDussen KL, Thomas D, et al. Notch signaling regulates gastric antral Lgr5 stem cell function. EMBO J. 2015; 34: 2522–36.

18

Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, et al. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. Nat Med. 2014; 20: 769–77.

19

Li H, Liu H, Chen K. Living biobank-based cancer organoids: prospects and challenges in cancer research. Cancer Biol Med. 2022; 19: 965–82.

20

Yang R, Yu Y. Artificial convolutional neural network in object detection and semantic segmentation for medical imaging analysis. Front Oncol. 2021; 11: 638182.

21

Yang R, Yan C, Lu S, Li J, Ji J, Yan R, et al. Tracking cancer lesions on surgical samples of gastric cancer by artificial intelligent algorithms. J Cancer. 2021; 12: 6473–83.

22

An F, Li X, Ma X. Medical image classification algorithm based on visual attention mechanism-MCNN. Oxid Med Cell Longev. 2021; 2021: 6280690.

23

Coudray N, Ocampo PS, Sakellaropoulos T, Narula N, Snuderl M, Fenyö D, et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med. 2018; 24: 1559–67.

24

Bian X, Li G, Wang C, Liu W, Lin X, Chen Z, et al. A deep learning model for detection and tracking in high-throughput images of organoid. Comput Biol Med. 2021; 134: 104490.

25

Larsen BM, Kannan M, Langer LF, Leibowitz BD, Bentaieb A, Cancino A, et al. A pan-cancer organoid platform for precision medicine. Cell Rep. 2021; 36: 109429.

26

Abdul L, Rajasekar S, Lin DSY, Venkatasubramania Raja S, Sotra A, Feng Y, et al. Deep-lumen assay - human lung epithelial spheroid classification from brightfield images using deep learning. Lab Chip. 2020; 20: 4623–31.

27

Okamoto T, Natsume Y, DoiM, Nosato H, Iwaki T, Yamanaka H, et al. Integration of human inspection and artificial intelligence-based morphological typing of patient-derived organoids reveals interpatient heterogeneity of colorectal cancer. Cancer Sci. 2022; 113: 2693–703.

28

Mohamad Kamal NS, Safuan S, Shamsuddin S, Foroozandeh P. Aging of the cells: insight into cellular senescence and detection methods. Eur J Cell Biol. 2020; 99: 151108.

29

Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15: 397–408.

30

Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Grützmann K, et al. Human gastric cancer modelling using organoids. Gut. 2019; 68: 207–17.

31

Everingham M, Gool LV, Williams CKI, Winn J, Zisserman A. The Pascal visual object classes (VOC) challenge. Int J Comput Vis. 2010; 88: 303–38.

32
Poojary R, Pai A. Comparative study of model optimization techniques in fine-tuned CNN models. 2019 International Conference on Electrical and Computing Technologies and Applications (ICECTA). 2019; 2019: 1–4.
33

Redmon J, Farhadi A. YOLOv3: an incremental improvement. arXiv e-prints. 2018. DOI: 10.48550/arXiv.1804.02767.

34
Bochkovskiy A, Wang CY, Liao H. YOLOv4: optimal speed and accuracy of object detection. 2020. DOI: 10.48550/arXiv:2004.10934.
35

Abadi M, Barham P, Chen J, Chen Z, Zhang X. Tensorflow: a system for large-scale machine learning. 12th Symposium on Operating Systems Design and Implementation. 2016; 2016: 265–283.

36

An P, Yang D, Wang J, Wu L, Zhou J, Zeng Z, et al. A deep learning method for delineating early gastric cancer resection margin under chromoendoscopy and white light endoscopy. Gastric Cancer. 2020; 23: 884–92.

37

Cai L, Gao J, Zhao D. A review of the application of deep learning in medical image classification and segmentation. Ann Transl Med. 2020; 8: 713.

38

Gao Y, Zhang ZD, Li S, Guo YT, Wu QY, Liu SH, et al. Deep neural network-assisted computed tomography diagnosis of metastatic lymph nodes from gastric cancer. Chin Med J (Engl). 2019; 132: 2804–11.

39

Hirasawa T, Aoyama K, Tanimoto T, Ishihara S, Shichijo S, Ozawa T, et al. Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images. Gastric Cancer. 2018; 21: 653–60.

40

Wickstrøm K, Kampffmeyer M, Jenssen R. Uncertainty and interpretability in convolutional neural networks for semantic segmentation of colorectal polyps. Med Image Anal. 2020; 60: 101619.

41

Wallaschek N, Niklas C, Pompaiah M, Wiegering A, Germer CT, Kircher S, et al. Establishing pure cancer organoid cultures: identification, selection and verification of cancer phenotypes and genotypes. J Mol Biol. 2019; 431: 2884–93.

42

Dijkstra KK, Monkhorst K, Schipper LJ, Hartemink KJ, Smit EF, Kaing S, et al. Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Rep. 2020; 31: 107588.

43

Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022; 12: 31–46.

44

Yang R, Yu Y. Patient-derived organoids in translational oncology and drug screening. Cancer Lett. 2023; 562: 216180.

45

Hoshi D, Kita E, Maru Y, Kogashi H, Nakamura Y, Tatsumi Y, et al. Derivation of pancreatic acinar cell carcinoma cell line HS-1 as a patient-derived tumor organoid. Cancer Sci. 2023; 114: 1165–79.

Cancer Biology & Medicine
Pages 519-536
Cite this article:
Yang R, Du Y, Kwan W, et al. A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids. Cancer Biology & Medicine, 2023, 20(7): 519-536. https://doi.org/10.20892/j.issn.2095-3941.2023.0099

53

Views

2

Downloads

1

Crossref

7

Web of Science

6

Scopus

Altmetrics

Received: 29 March 2023
Accepted: 11 May 2023
Published: 30 June 2023
©2023 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License

Return